Supporting African communities to increase resilience and mental health of kids with developmental disabilities and their caregivers using the World Health Organization's Caregiver Skills Training Programme (SPARK trial): study protocol for a cluster randomised clinical controlled trial.

Autor: Washington-Nortey M; Department of Psychology, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK., Angwenyi V; Institute for Human Development, Aga Khan University, P.O. Box 30270-00100, Nairobi, Kenya., Demissie M; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Mwangome E; Neuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya., Eshetu T; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Negussie H; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Goldsmith K; Department of Biostatistics and Health Informatics, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK., Healey A; Health Service and Population Research, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK., Feyasa M; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Medhin G; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Belay A; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Azmeraw T; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Getachew M; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Birhane R; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Nasambu C; Neuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya., Kifle TH; Department of Psychology, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK., Kairu A; Neuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya., Mkubwa B; Institute for Human Development, Aga Khan University, P.O. Box 30270-00100, Nairobi, Kenya., Girma F; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Abdurahman R; Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia., Tsigebrhan R; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Tesfaye L; Nia Foundation, Joy Center for Autism, Addis Ababa, Ethiopia., Mbonani L; Kuhenza for Children's Foundation, Kilifi, Kenya., Seward N; School of Health and Social Science, University of Edinburgh, Edinburgh, UK., Charman T; Department of Psychology, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK., Pickles A; Department of Biostatistics and Health Informatics, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK., Salomone E; University of Milano-Bicocca, Milan, Italy.; Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland., Servili C; Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland., Barasa E; Neuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya., Newton CR; Neuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya.; Department of Psychiatry, University of Oxford, Oxford, OX3 7FZ, UK., Hanlon C; Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.; Department of Psychiatry, WHO Collaborating Centre in Mental Health Research and Capacity-Building, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.; Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK., Abubakar A; Institute for Human Development, Aga Khan University, P.O. Box 30270-00100, Nairobi, Kenya.; Neuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya., Hoekstra RA; Department of Psychology, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK. rosa.hoekstra@kcl.ac.uk.

Publikováno v: Trials [Trials] 2024 Oct 24; Vol. 25 (1), pp. 713. Date of Electronic Publication: 2024 Oct 24.